Disease Areas:
CoughDevice Types:
VitaloJAKThis pooled analysis examined the medical histories and clinical characteristics of 2044 adult patients with refractory or unexplained chronic cough enrolled in the Phase 3 COUGH-1 and COUGH-2 trials. In both studies, objective 24-hour cough frequency was calculated from recordings captured using the Vitalograph VitaloJAK device.